NEWS DETAIL

FDA erteilt Zulassung für Lumakras® (Sotorasib) in Kombination mit Vectibix® (Panitumumab) zur Behandlung von chemotherapieresistentem, metastasiertem Darmkrebs mit KRAS-G12C-Mutation – PR Newswire

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER PR Newswire

Medizinische Informationen July 20, 2026

该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Produkte zu diesem Artikel

Diese Produkte wurden automatisch anhand von Titel, Zusammenfassung und Inhalt zugeordnet.

Haeufig gestellte Fragen

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Sotorasib – Online kaufen SOTOLDX Sotorasib 120 mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.